Company / Cost of Revenue
Artivion Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$157.1M
FY2025
5-year range
$85.4M / $157.1M
FY2021-FY2025
Trend
+12.4%
vs FY2024
Sector context
#84 of 113
Health Care
What the data says
At $157M, Artivion's cost of revenue ranks #30 of 113 in the Health Care sector. Cost of Revenue has increased for 3 consecutive years, from $85M in FY2022 to $157M in FY2025.
Based on SEC 10-K filings.
$157M in FY2025 with a 5-year CAGR of +11.8%.
Increased from $125M to $157M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +22.5%
- 5-Year CAGR
- +11.8%
- 10-Year CAGR
- -
Sector benchmark
#30 of 113 in Health CareTop 26% of 113This company $157.1M Sector average $11.3B
▼
-98.6% below sector average
Key checks
Key Insights
- Artivion's cost of revenue has grown for 3 consecutive years.
- 5-year CAGR of +11.8%, indicating consistent growth.
- In FY2025, cost of revenue increased 12.4% year-over-year.
- Ranks #84 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $157.1M | +12.4% |
| FY2024 | $139.8M | +12.0% |
| FY2023 | $124.8M | +46.1% |
| FY2022 | $85.4M | -8.3% |
| FY2021 | $93.2M | +3.7% |
| FY2020 | $89.9M | +47.2% |
| FY2019 | $61.1M | -0.7% |
| FY2018 | $61.5M | +11.4% |
| FY2017 | $55.2M | +3.4% |
| FY2016 | $53.4M | +5.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026